TOPIRAMATE

TOPIRAMATE was reported 50793 times

These side effects are most commonly reported by patients taking TOPIRAMATE:

# Side effect Count
0 DRUG INEFFECTIVE 7062
1 OFF LABEL USE 5701
2 HEADACHE 3701
3 NAUSEA 3349
4 FATIGUE 3212
5 PRODUCT USE IN UNAPPROVED INDICATION 2627
6 PAIN 2577
7 MIGRAINE 2555
8 DIZZINESS 2441
9 SEIZURE 2293
10 DIARRHOEA 2219
11 CONDITION AGGRAVATED 2218
12 VOMITING 2197
13 DRUG INTOLERANCE 2143
14 DEPRESSION 1978
15 PARAESTHESIA 1828
16 RASH 1807
17 WEIGHT INCREASED 1801
18 DYSPNOEA 1755
19 FALL 1728
20 SOMNOLENCE 1618
21 ARTHRALGIA 1612
22 PRODUCT USE ISSUE 1608
23 MEMORY IMPAIRMENT 1601
24 CONFUSIONAL STATE 1552
25 MALAISE 1538
26 HYPOAESTHESIA 1535
27 INSOMNIA 1526
28 WEIGHT DECREASED 1487
29 DRUG INTERACTION 1483
30 TOXICITY TO VARIOUS AGENTS 1469
31 EPILEPSY 1466
32 ASTHENIA 1464
33 ALOPECIA 1404
34 PNEUMONIA 1343
35 PAIN IN EXTREMITY 1322
36 DECREASED APPETITE 1319
37 TREATMENT FAILURE 1309
38 ANXIETY 1294
39 COMPLETED SUICIDE 1275
40 MATERNAL EXPOSURE DURING PREGNANCY 1254
41 GASTROOESOPHAGEAL REFLUX DISEASE 1245
42 ABDOMINAL PAIN UPPER 1228
43 DRUG HYPERSENSITIVITY 1170
44 ABDOMINAL DISCOMFORT 1120
45 HYPERTENSION 1117
46 INTENTIONAL PRODUCT USE ISSUE 1095
47 HYPERSENSITIVITY 1052
48 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1045
49 MUSCLE SPASMS 1036
50 URTICARIA 994
51 PYREXIA 993
52 SYSTEMIC LUPUS ERYTHEMATOSUS 993
53 WHEEZING 986
54 RHEUMATOID ARTHRITIS 984
55 TREMOR 982
56 SWELLING 981
57 GAIT DISTURBANCE 979
58 DYSPEPSIA 975
59 PERIPHERAL SWELLING 974
60 NASOPHARYNGITIS 968
61 MUSCULAR WEAKNESS 959
62 WOUND 955
63 DRY MOUTH 954
64 GENERAL PHYSICAL HEALTH DETERIORATION 947
65 FOETAL EXPOSURE DURING PREGNANCY 933
66 SLEEP DISORDER 928
67 OVERDOSE 925
68 PRURITUS 914
69 NECK PAIN 885
70 TYPE 2 DIABETES MELLITUS 885
71 FIBROMYALGIA 879
72 SYNOVITIS 865
73 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 864
74 PSORIATIC ARTHROPATHY 854
75 ABDOMINAL PAIN 844
76 NEPHROLITHIASIS 836
77 CONTRAINDICATED PRODUCT ADMINISTERED 832
78 FEELING ABNORMAL 829
79 MOBILITY DECREASED 828
80 JOINT SWELLING 823
81 PRODUCT DOSE OMISSION ISSUE 817
82 PEMPHIGUS 814
83 INJURY 813
84 INFUSION RELATED REACTION 809
85 WOUND INFECTION 804
86 FOLLICULITIS 799
87 GLOSSODYNIA 795
88 PERICARDITIS 794
89 PRODUCT QUALITY ISSUE 792
90 TASTE DISORDER 783
91 GASTROINTESTINAL DISORDER 781
92 DEATH 772
93 BURSITIS 769
94 HEPATIC ENZYME INCREASED 762
95 ARTHROPATHY 749
96 GAIT INABILITY 748
97 COUGH 739
98 BLOOD CHOLESTEROL INCREASED 737
99 THERAPEUTIC PRODUCT EFFECT DECREASED 737
100 SUICIDAL IDEATION 733
101 BLEPHAROSPASM 731
102 MUSCULOSKELETAL STIFFNESS 724
103 INFLAMMATION 723
104 OSTEOARTHRITIS 723
105 BLISTER 722
106 COGNITIVE DISORDER 706
107 EXPOSURE DURING PREGNANCY 704
108 HAND DEFORMITY 702
109 C-REACTIVE PROTEIN INCREASED 698
110 BACK PAIN 694
111 LOWER RESPIRATORY TRACT INFECTION 694
112 CHEST PAIN 691
113 ABDOMINAL DISTENSION 688
114 JOINT RANGE OF MOTION DECREASED 683
115 SEDATION 682
116 IRRITABLE BOWEL SYNDROME 680
117 CHRONIC KIDNEY DISEASE 679
118 HYPERHIDROSIS 679
119 ACUTE KIDNEY INJURY 676
120 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 675
121 HYPOTENSION 674
122 STOMATITIS 669
123 CONVULSION 668
124 NAIL DISORDER 650
125 DUODENAL ULCER PERFORATION 647
126 CONSTIPATION 643
127 BREAST CANCER STAGE III 640
128 FACET JOINT SYNDROME 625
129 VISION BLURRED 624
130 STATUS EPILEPTICUS 621
131 NIGHT SWEATS 619
132 HELICOBACTER INFECTION 615
133 LUNG DISORDER 593
134 LIP DRY 591
135 MULTIPLE-DRUG RESISTANCE 585
136 IMPAIRED HEALING 582
137 OBESITY 580
138 SINUSITIS 575
139 BACK INJURY 571
140 URINARY TRACT INFECTION 571
141 LIVER INJURY 568
142 ONYCHOMADESIS 563
143 AGGRESSION 562
144 MUSCULOSKELETAL PAIN 561
145 PERIPHERAL VENOUS DISEASE 557
146 MUSCLE INJURY 556
147 AMNESIA 545
148 HYPERCHOLESTEROLAEMIA 544
149 PRODUCT SUBSTITUTION ISSUE 544
150 RHEUMATIC FEVER 537
151 ASTHMA 535
152 LIVER FUNCTION TEST INCREASED 529
153 GRIP STRENGTH DECREASED 525
154 CONTUSION 519
155 VISUAL IMPAIRMENT 518
156 LIVE BIRTH 514
157 DISTURBANCE IN ATTENTION 513
158 ILL-DEFINED DISORDER 513
159 LOSS OF CONSCIOUSNESS 512
160 COVID-19 504
161 METABOLIC ACIDOSIS 497
162 DISCOMFORT 496
163 INFECTION 481
164 DRUG-INDUCED LIVER INJURY 478
165 IRRITABILITY 466
166 THERAPY NON-RESPONDER 466
167 INJECTION SITE REACTION 463
168 DRUG RESISTANCE 462
169 INTENTIONAL OVERDOSE 459
170 RENAL FAILURE 456
171 C-REACTIVE PROTEIN ABNORMAL 444
172 FINGER DEFORMITY 442
173 BALANCE DISORDER 440
174 SUICIDE ATTEMPT 440
175 HEPATITIS 430
176 AGITATION 422
177 ANGLE CLOSURE GLAUCOMA 422
178 COELIAC DISEASE 422
179 GENERALISED TONIC-CLONIC SEIZURE 419
180 INJECTION SITE PAIN 417
181 SWELLING FACE 412
182 HOSPITALISATION 407
183 NIGHTMARE 407
184 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 406
185 ADVERSE EVENT 404
186 PALPITATIONS 404
187 DYSPHONIA 397
188 PRODUCT LABEL CONFUSION 397
189 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 394
190 ONYCHOMYCOSIS 394
191 SPEECH DISORDER 392
192 DRUG ABUSE 384
193 ADVERSE REACTION 371
194 CARDIAC ARREST 366
195 MYALGIA 364
196 INTENTIONAL PRODUCT MISUSE 360
197 BLOOD PRESSURE INCREASED 359
198 INCORRECT DOSE ADMINISTERED 357
199 DEPRESSED MOOD 356
200 DYSARTHRIA 355
201 STRESS 353
202 TACHYCARDIA 346
203 PSYCHOTIC DISORDER 345
204 ADVERSE DRUG REACTION 338
205 EYE PAIN 338
206 HALLUCINATION 338
207 PRESCRIBED OVERDOSE 338
208 INFLUENZA 330
209 SEROTONIN SYNDROME 330
210 VERTIGO 328
211 UNDERDOSE 326
212 ERYTHEMA 325
213 ROAD TRAFFIC ACCIDENT 323
214 DEHYDRATION 322
215 SWOLLEN TONGUE 321
216 SYNCOPE 319
217 FLUSHING 317
218 APHASIA 315
219 ILLNESS 313
220 HEART RATE INCREASED 312
221 LETHARGY 310
222 OEDEMA PERIPHERAL 309
223 CONGENITAL ANOMALY 307
224 PSORIASIS 307
225 BRONCHITIS 304
226 DEPRESSED LEVEL OF CONSCIOUSNESS 302
227 MULTIPLE SCLEROSIS RELAPSE 302
228 ABORTION SPONTANEOUS 299
229 ANGIOEDEMA 299
230 OROPHARYNGEAL PAIN 293
231 PRESCRIBED UNDERDOSE 292
232 ATAXIA 291
233 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 290
234 BRADYCARDIA 286
235 TREATMENT NONCOMPLIANCE 283
236 ABNORMAL BEHAVIOUR 280
237 DYSPHAGIA 278
238 CARDIO-RESPIRATORY ARREST 272
239 DRUG DOSE OMISSION 272
240 DELIRIUM 271
241 DYSGEUSIA 271
242 ELECTROCARDIOGRAM QT PROLONGED 268
243 ANAEMIA 265
244 HYPOKALAEMIA 263
245 DISORIENTATION 260
246 THERAPEUTIC RESPONSE DECREASED 258
247 TINNITUS 256
248 LOWER LIMB FRACTURE 254
249 FEELING HOT 250
250 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 249
251 MEDICATION ERROR 249
252 CHEST DISCOMFORT 247
253 THROMBOCYTOPENIA 247
254 NEUROPATHY PERIPHERAL 246
255 MENTAL DISORDER 245
256 PULMONARY EMBOLISM 241
257 CEREBROVASCULAR ACCIDENT 239
258 ENCEPHALOPATHY 239
259 PETIT MAL EPILEPSY 236
260 DIPLOPIA 234
261 RESPIRATORY FAILURE 234
262 OEDEMA 233
263 RENAL TUBULAR ACIDOSIS 231
264 ARTHRITIS 228
265 SEPSIS 228
266 COMA 227
267 WITHDRAWAL SYNDROME 223
268 ANGER 222
269 HYPERAMMONAEMIA 222
270 CHILLS 221
271 NASAL CONGESTION 219
272 OSTEOPOROSIS 219
273 PARTIAL SEIZURES 219
274 PHOTOPHOBIA 219
275 NO ADVERSE EVENT 217
276 EMOTIONAL DISTRESS 216
277 NEUTROPENIA 216
278 ANAPHYLACTIC REACTION 213
279 BURNING SENSATION 213
280 DYSKINESIA 213
281 MYOCLONUS 213
282 EPISTAXIS 212
283 INFLUENZA LIKE ILLNESS 210
284 MYOPIA 210
285 EAR PAIN 206
286 DRUG DEPENDENCE 205
287 MULTIPLE SCLEROSIS 203
288 UPPER RESPIRATORY TRACT INFECTION 200
289 RHINORRHOEA 199
290 INFUSION SITE REACTION 198
291 WHITE BLOOD CELL COUNT DECREASED 198
292 RESPIRATORY ARREST 196
293 MENTAL IMPAIRMENT 193
294 BLOOD GLUCOSE INCREASED 190
295 DRUG EXPOSURE DURING PREGNANCY 190
296 RESPIRATORY DISORDER 190
297 LIVER DISORDER 188
298 CRYING 187
299 PRODUCT DOSE OMISSION 185
300 CHOROIDAL EFFUSION 184
301 MOOD SWINGS 183
302 BLINDNESS 182
303 RHEUMATOID FACTOR POSITIVE 182
304 DRY SKIN 181
305 RHABDOMYOLYSIS 181
306 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 181
307 SURGERY 181
308 EAR INFECTION 180
309 INJECTION SITE ERYTHEMA 180
310 MOOD ALTERED 180
311 PLATELET COUNT DECREASED 179
312 RESTLESSNESS 179
313 MUSCLE TWITCHING 178
314 PULMONARY FIBROSIS 178
315 RASH PRURITIC 178
316 UNEVALUABLE EVENT 178
317 NERVOUSNESS 177
318 SCIATICA 177
319 DEEP VEIN THROMBOSIS 176
320 DISEASE RECURRENCE 176
321 CROHN^S DISEASE 174
322 HYPERSOMNIA 173
323 DISLOCATION OF VERTEBRA 172
324 HALLUCINATION, VISUAL 172
325 PANIC ATTACK 172
326 PRODUCTIVE COUGH 172
327 THERAPEUTIC RESPONSE UNEXPECTED 170
328 BLOOD PRESSURE DECREASED 167
329 MYOCARDIAL INFARCTION 164
330 HOT FLUSH 163
331 HEAD DISCOMFORT 161
332 PARANOIA 161
333 THROMBOSIS 161
334 SWOLLEN JOINT COUNT INCREASED 160
335 THERAPY INTERRUPTED 160
336 CATARACT 159
337 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 159
338 UNRESPONSIVE TO STIMULI 158
339 PNEUMONIA ASPIRATION 157
340 URINARY INCONTINENCE 157
341 IMPAIRED GASTRIC EMPTYING 156
342 DRY EYE 155
343 JOINT STIFFNESS 155
344 HEPATIC CIRRHOSIS 154
345 OXYGEN SATURATION DECREASED 154
346 ALANINE AMINOTRANSFERASE INCREASED 153
347 FLUID RETENTION 153
348 HAEMORRHAGE 153
349 HALLUCINATION, AUDITORY 153
350 PANCREATITIS 153
351 RENAL INJURY 153
352 HEAD INJURY 152
353 HYPERAMMONAEMIC ENCEPHALOPATHY 152
354 NORMAL NEWBORN 151
355 HYPONATRAEMIA 150
356 APATHY 147
357 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 146
358 DIABETES MELLITUS 145
359 THERAPY PARTIAL RESPONDER 145
360 DRUG WITHDRAWAL SYNDROME 143
361 DYSSTASIA 143
362 GRAND MAL CONVULSION 142
363 MYOCLONIC EPILEPSY 142
364 RENAL IMPAIRMENT 142
365 THERAPY CESSATION 142
366 LARYNGITIS 141
367 MANIA 141
368 EXOSTOSIS 140
369 BLOOD POTASSIUM DECREASED 139
370 CARDIAC DISORDER 139
371 POOR QUALITY SLEEP 139
372 MIDDLE INSOMNIA 138
373 HERPES ZOSTER 136
374 NEURALGIA 136
375 WHITE BLOOD CELL COUNT INCREASED 136
376 BLOOD CREATINE PHOSPHOKINASE INCREASED 134
377 HAEMOGLOBIN DECREASED 134
378 SKIN EXFOLIATION 134
379 INJECTION SITE BRUISING 133
380 RED BLOOD CELL SEDIMENTATION RATE INCREASED 133
381 AUTOIMMUNE DISORDER 131
382 BONE PAIN 131
383 CELLULITIS 131
384 URINARY RETENTION 131
385 VISUAL ACUITY REDUCED 131
386 BRADYPHRENIA 130
387 BREAST CANCER STAGE II 130
388 DYSURIA 130
389 ARRHYTHMIA 127
390 BEHAVIOUR DISORDER 127
391 HEMIPARESIS 127
392 MATERNAL DRUGS AFFECTING FOETUS 127
393 DELUSION 126
394 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 125
395 DISABILITY 125
396 DYSTONIA 125
397 ULCER HAEMORRHAGE 125
398 LUPUS-LIKE SYNDROME 124
399 MOVEMENT DISORDER 124
400 SLEEP APNOEA SYNDROME 123
401 NERVOUS SYSTEM DISORDER 122
402 RECTAL HAEMORRHAGE 121
403 MEDICATION OVERUSE HEADACHE 120
404 ACCIDENTAL OVERDOSE 119
405 INJECTION SITE SWELLING 119
406 BRAIN FOG 117
407 CONCUSSION 117
408 COORDINATION ABNORMAL 117
409 RESTLESS LEGS SYNDROME 117
410 EATING DISORDER 116
411 POLLAKIURIA 116
412 BIPOLAR DISORDER 115
413 EYE IRRITATION 115
414 EMOTIONAL DISORDER 114
415 END STAGE RENAL DISEASE 114
416 FEAR 114
417 NEUROLEPTIC MALIGNANT SYNDROME 114
418 THROAT IRRITATION 114
419 EXTRAPYRAMIDAL DISORDER 113
420 HEART RATE DECREASED 113
421 PREGNANCY 113
422 DRUG LEVEL INCREASED 112
423 INJECTION SITE PRURITUS 112
424 INTENTIONAL SELF-INJURY 112
425 LIMB DISCOMFORT 112
426 SKIN DISCOLOURATION 112
427 ALTERED STATE OF CONSCIOUSNESS 111
428 ASPARTATE AMINOTRANSFERASE INCREASED 111
429 NYSTAGMUS 111
430 BACK DISORDER 109
431 HYPERTHERMIA 109
432 LEUKOPENIA 109
433 RASH ERYTHEMATOUS 109
434 THINKING ABNORMAL 109
435 BODY TEMPERATURE INCREASED 108
436 DISEASE PROGRESSION 108
437 BONE EROSION 107
438 CHOLELITHIASIS 107
439 SINUS DISORDER 107
440 DRUG EFFECT DECREASED 106
441 FLATULENCE 106
442 AMMONIA INCREASED 105
443 HYPOTHYROIDISM 105
444 INJECTION SITE HAEMORRHAGE 105
445 MENTAL STATUS CHANGES 105
446 PRE-EXISTING CONDITION IMPROVED 105
447 HEAT STROKE 104
448 INCORRECT PRODUCT ADMINISTRATION DURATION 104
449 LUPUS VULGARIS 104
450 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 104
451 X-RAY ABNORMAL 104
452 LIP SWELLING 103
453 VIRAL INFECTION 103
454 DRUG TOLERANCE 102
455 VITAMIN D DEFICIENCY 102
456 ACNE 101
457 BRAIN OEDEMA 101
458 INTENTIONAL DOSE OMISSION 101
459 SHOCK 101
460 RIB FRACTURE 100
461 DEEP VEIN THROMBOSIS POSTOPERATIVE 99
462 GASTROINTESTINAL HAEMORRHAGE 99
463 HYPOPHAGIA 99
464 LYMPHADENOPATHY 99
465 OCULAR HYPERAEMIA 99
466 PSYCHOMOTOR HYPERACTIVITY 99
467 ACCIDENTAL EXPOSURE TO PRODUCT 98
468 PARADOXICAL DRUG REACTION 98
469 PRODUCT ADMINISTRATION INTERRUPTED 98
470 EYE SWELLING 97
471 HYPOGLYCAEMIA 97
472 MULTIPLE ORGAN DYSFUNCTION SYNDROME 97
473 SOMNAMBULISM 97
474 ACIDOSIS HYPERCHLORAEMIC 96
475 DERMATITIS ATOPIC 96
476 HYPOSPADIAS 96
477 AFFECTIVE DISORDER 95
478 ATRIAL FIBRILLATION 95
479 AUTISM SPECTRUM DISORDER 95
480 DRUG EFFECT INCOMPLETE 95
481 INTERVERTEBRAL DISC PROTRUSION 95
482 DRUG TOXICITY 94
483 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 94
484 PREMATURE BABY 94
485 RENAL DISORDER 94
486 FEELING COLD 93
487 IMPAIRED WORK ABILITY 93
488 ASPIRATION 92
489 ERECTILE DYSFUNCTION 92
490 HYPOTHERMIA 92
491 AMENORRHOEA 91
492 FUNGAL INFECTION 91
493 HYPOACUSIS 91
494 MAJOR DEPRESSION 91
495 RESPIRATORY DISTRESS 91
496 OBSTRUCTIVE AIRWAYS DISORDER 90
497 OVERLAP SYNDROME 90
498 RESPIRATORY TRACT INFECTION 90
499 TRANSIENT ISCHAEMIC ATTACK 90
500 TUBULOINTERSTITIAL NEPHRITIS 90
501 ANHEDONIA 89
502 FEEDING DISORDER 89
503 FOOT FRACTURE 89
504 FREQUENT BOWEL MOVEMENTS 89
505 MYDRIASIS 89
506 POST-TRAUMATIC STRESS DISORDER 89
507 STAPHYLOCOCCAL INFECTION 89
508 STEVENS-JOHNSON SYNDROME 89
509 CYSTITIS 88
510 HYPOTONIA 88
511 HYPOKINESIA 87
512 NEOPLASM MALIGNANT 87
513 POISONING 87
514 PRODUCT DOSE OMISSION IN ERROR 87
515 SMALL FOR DATES BABY 87
516 VISUAL FIELD DEFECT 87
517 BLOOD CREATININE INCREASED 86
518 DEVELOPMENTAL DELAY 86
519 SEASONAL ALLERGY 86
520 INTESTINAL OBSTRUCTION 85
521 PHOTOSENSITIVITY REACTION 85
522 EYE DISORDER 84
523 PRODUCT PHYSICAL ISSUE 84
524 SUSPECTED SUICIDE 84
525 TONIC CONVULSION 84
526 ATRIAL SEPTAL DEFECT 83
527 CARDIAC FAILURE CONGESTIVE 83
528 HEPATIC ENZYME 83
529 KNEE ARTHROPLASTY 83
530 FANCONI SYNDROME 82
531 MOUTH ULCERATION 82
532 SENSORY DISTURBANCE 82
533 THROAT TIGHTNESS 82
534 ACUTE HEPATIC FAILURE 81
535 BRAIN INJURY 81
536 INTRAOCULAR PRESSURE INCREASED 81
537 MACULOPATHY 81
538 PULMONARY OEDEMA 81
539 THIRST 81
540 CANDIDA INFECTION 80
541 DRUG LEVEL DECREASED 80
542 SEPTIC SHOCK 80
543 SINUS TACHYCARDIA 80
544 DEVICE ISSUE 79
545 APNOEA 78
546 CENTRAL NERVOUS SYSTEM LESION 78
547 FOOT DEFORMITY 78
548 THYROID DISORDER 78
549 DIVERTICULITIS 77
550 HYPOCALCAEMIA 77
551 OSTEOPENIA 77
552 THERAPEUTIC RESPONSE SHORTENED 77
553 VAGINAL HAEMORRHAGE 77
554 LABORATORY TEST ABNORMAL 76
555 PRODUCT AVAILABILITY ISSUE 76
556 RASH MACULO-PAPULAR 76
557 TEMPERATURE INTOLERANCE 76
558 BLOOD ALKALINE PHOSPHATASE INCREASED 75
559 DYSMORPHISM 75
560 DYSPNOEA EXERTIONAL 75
561 GLAUCOMA 75
562 KIDNEY INFECTION 75
563 CARDIAC FAILURE 74
564 DEVICE MALFUNCTION 74
565 COMMUNICATION DISORDER 73
566 DRUG ERUPTION 73
567 IMMUNODEFICIENCY 73
568 MOTOR DYSFUNCTION 73
569 SKIN BURNING SENSATION 73
570 ECONOMIC PROBLEM 72
571 EYE MOVEMENT DISORDER 72
572 HYPOXIA 72
573 IMPAIRED DRIVING ABILITY 72
574 IMPAIRED QUALITY OF LIFE 72
575 MIGRAINE WITH AURA 72
576 VISUAL PERSEVERATION 72
577 ELECTROENCEPHALOGRAM ABNORMAL 71
578 GASTROENTERITIS VIRAL 71
579 INJECTION SITE MASS 71
580 LIVER FUNCTION TEST ABNORMAL 71
581 PARAESTHESIA ORAL 71
582 PRODUCT PRESCRIBING ERROR 71
583 SLUGGISHNESS 71
584 SPUTUM DISCOLOURED 71
585 WALKING AID USER 71
586 ACIDOSIS 70
587 BONE DISORDER 70
588 CLEFT LIP AND PALATE 70
589 LOW BIRTH WEIGHT BABY 70
590 PROCEDURAL PAIN 70
591 SCAR 70
592 EAR DISCOMFORT 69
593 LACRIMATION INCREASED 69
594 PLEURAL EFFUSION 69
595 ANAL INCONTINENCE 68
596 CHROMATURIA 68
597 ECZEMA 68
598 LYMPHOCYTE COUNT DECREASED 68
599 NEPHROGENIC ANAEMIA 68
600 PAIN OF SKIN 68
601 PALLOR 68
602 PANCYTOPENIA 68
603 PORPHYRIA ACUTE 68
604 SKIN DISORDER 68
605 UVEITIS 68
606 HAEMATOCHEZIA 67
607 HEPATIC FUNCTION ABNORMAL 67
608 INITIAL INSOMNIA 67
609 PAIN IN JAW 67
610 REBOUND EFFECT 67
611 BLOOD PRESSURE FLUCTUATION 66
612 GASTRIC DISORDER 66
613 HIP ARTHROPLASTY 66
614 INTELLECTUAL DISABILITY 66
615 AFFECT LABILITY 65
616 COLITIS ULCERATIVE 65
617 LIMB INJURY 65
618 SKIN CANCER 65
619 AGEUSIA 64
620 ANURIA 64
621 CHOKING 64
622 FACIAL PAIN 64
623 INJECTION SITE URTICARIA 64
624 TACHYPNOEA 64
625 ANGINA PECTORIS 63
626 BREAST CANCER 63
627 INFANTILE SPASMS 63
628 PSYCHOMOTOR SKILLS IMPAIRED 63
629 RASH PAPULAR 63
630 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 63
631 EOSINOPHIL COUNT INCREASED 62
632 HAEMODYNAMIC INSTABILITY 62
633 NEUROTOXICITY 62
634 RASH MACULAR 62
635 RENAL FAILURE ACUTE 62
636 SOCIAL AVOIDANT BEHAVIOUR 62
637 WRONG TECHNIQUE IN DRUG USAGE PROCESS 62
638 EYE PRURITUS 61
639 HYPOAESTHESIA ORAL 61
640 REBOUND ACID HYPERSECRETION 61
641 TOXIC ENCEPHALOPATHY 61
642 ABNORMAL LOSS OF WEIGHT 60
643 ACUTE MYOPIA 60
644 AGRANULOCYTOSIS 60
645 JOINT DISLOCATION 60
646 JOINT INJURY 60
647 MUSCLE SPASTICITY 60
648 PARALYSIS 60
649 PSYCHOMOTOR RETARDATION 60
650 SNEEZING 60
651 VENTRICULAR SEPTAL DEFECT 60
652 CEREBRAL VENOUS THROMBOSIS 59
653 CHOROIDAL DETACHMENT 59
654 COLITIS 59
655 GAMMA-GLUTAMYLTRANSFERASE INCREASED 59
656 HAIR TEXTURE ABNORMAL 59
657 INCREASED APPETITE 59
658 NECROTISING COLITIS 59
659 NEEDLE ISSUE 59
660 NERVE INJURY 59
661 TEARFULNESS 59
662 TOOTHACHE 59
663 ABNORMAL DREAMS 58
664 ACUTE RESPIRATORY FAILURE 58
665 AUTONOMIC NERVOUS SYSTEM IMBALANCE 58
666 BEDRIDDEN 58
667 BLOOD LACTIC ACID INCREASED 58
668 COAGULOPATHY 58
669 DEAFNESS 58
670 GASTRITIS 58
671 HIP FRACTURE 58
672 INSURANCE ISSUE 58
673 NEPHROPATHY TOXIC 58
674 PERIPHERAL COLDNESS 58
675 RASH GENERALISED 58
676 SALIVARY HYPERSECRETION 58
677 TARDIVE DYSKINESIA 58
678 ACTIVITIES OF DAILY LIVING IMPAIRED 57
679 HEPATIC FAILURE 57
680 RENAL PAIN 57
681 SKIN LESION 57
682 TOOTH DISORDER 57
683 UPPER-AIRWAY COUGH SYNDROME 57
684 ADRENAL INSUFFICIENCY 56
685 CATATONIA 56
686 CORNEAL OEDEMA 56
687 PETECHIAE 56
688 QUALITY OF LIFE DECREASED 56
689 SENSORY LOSS 56
690 DECREASED ACTIVITY 55
691 FEELING DRUNK 55
692 FEELING JITTERY 55
693 INTERVERTEBRAL DISC DEGENERATION 55
694 ORTHOSTATIC HYPOTENSION 55
695 OVARIAN CYST 55
696 PRESYNCOPE 55
697 RETINITIS 55
698 SUICIDAL BEHAVIOUR 55
699 APHONIA 54
700 BODY TEMPERATURE DECREASED 54
701 BRADYKINESIA 54
702 CIRCULATORY COLLAPSE 54
703 DRUG EFFECT LESS THAN EXPECTED 54
704 HEPATOTOXICITY 54
705 HYPOCHOLESTEROLAEMIA 54
706 INFUSION SITE PAIN 54
707 LEUKOCYTOSIS 54
708 PHARYNGITIS 54
709 PRODUCT ADMINISTRATION ERROR 54
710 PRURITUS GENERALISED 54
711 RESPIRATORY DEPRESSION 54
712 TOOTH INFECTION 54
713 DEVICE DISLOCATION 53
714 DRUG TOLERANCE DECREASED 53
715 ENURESIS 53
716 FLAT ANTERIOR CHAMBER OF EYE 53
717 HAEMATOMA 53
718 HEART RATE IRREGULAR 53
719 INCOHERENT 53
720 INTERNATIONAL NORMALISED RATIO INCREASED 53
721 MUSCULOSKELETAL DISCOMFORT 53
722 MYOCARDITIS 53
723 NO THERAPEUTIC RESPONSE 53
724 PHONOPHOBIA 53
725 RETCHING 53
726 ABASIA 52
727 AURA 52
728 BLOOD GLUCOSE DECREASED 52
729 CLEFT LIP 52
730 CLUMSINESS 52
731 DENTAL CARIES 52
732 DERMATITIS CONTACT 52
733 EYELID PTOSIS 52
734 HAEMATOCRIT DECREASED 52
735 INJECTION SITE RASH 52
736 MUSCLE RIGIDITY 52
737 NEOVASCULARISATION 52
738 ROTATOR CUFF SYNDROME 52
739 ANTICONVULSANT DRUG LEVEL INCREASED 51
740 BLOOD URINE PRESENT 51
741 CHANGE IN SEIZURE PRESENTATION 51
742 DERMATITIS ALLERGIC 51
743 DRUG DOSE OMISSION BY DEVICE 51
744 GASTRIC ULCER 51
745 HAEMORRHOIDS 51
746 HEPATIC STEATOSIS 51
747 PRODUCT DISPENSING ERROR 51
748 UPPER LIMB FRACTURE 51
749 VITAMIN D DECREASED 51
750 WRONG PATIENT RECEIVED PRODUCT 51
751 BLOOD PROLACTIN INCREASED 50
752 DEVICE BREAKAGE 50
753 FOETAL GROWTH RESTRICTION 50
754 INCONTINENCE 50
755 MADAROSIS 50
756 PANCREATITIS ACUTE 50
757 PSYCHIATRIC SYMPTOM 50
758 SCRATCH 50
759 SPINAL FRACTURE 50
760 ATONIC SEIZURES 49
761 CEREBRAL HAEMORRHAGE 49
762 FEBRILE NEUTROPENIA 49
763 HYPERNATRAEMIA 49
764 LIBIDO INCREASED 49
765 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 49
766 MUSCULOSKELETAL DISORDER 49
767 PERSONALITY DISORDER 49
768 PRIAPISM 49
769 RESPIRATORY TRACT CONGESTION 49
770 SINUS CONGESTION 49
771 SINUS PAIN 49
772 TOOTH FRACTURE 49
773 BLOOD PRESSURE SYSTOLIC INCREASED 48
774 CARPAL TUNNEL SYNDROME 48
775 COMPLEX PARTIAL SEIZURES 48
776 HYPERACUSIS 48
777 HYPERGLYCAEMIA 48
778 MYOSITIS 48
779 PAROSMIA 48
780 PHARYNGITIS STREPTOCOCCAL 48
781 PRODUCT STORAGE ERROR 48
782 SKIN ULCER 48
783 CLUSTER HEADACHE 47
784 EUPHORIC MOOD 47
785 GINGIVAL BLEEDING 47
786 HYPOHIDROSIS 47
787 LIGAMENT SPRAIN 47
788 ORAL PAIN 47
789 PREMATURE DELIVERY 47
790 PRODUCT PRESCRIBING ISSUE 47
791 PROPOFOL INFUSION SYNDROME 47
792 PUSTULAR PSORIASIS 47
793 SPINAL OSTEOARTHRITIS 47
794 WEIGHT FLUCTUATION 47
795 ANKLE FRACTURE 46
796 BRAIN HERNIATION 46
797 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 46
798 FULL BLOOD COUNT ABNORMAL 46
799 HEMIPLEGIA 46
800 HYDRONEPHROSIS 46
801 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 46
802 OPTIC NEURITIS 46
803 SKIN LACERATION 46
804 ACUTE RESPIRATORY DISTRESS SYNDROME 45
805 AKATHISIA 45
806 DEMENTIA 45
807 DERMATITIS 45
808 DEVICE DIFFICULT TO USE 45
809 ERUCTATION 45
810 FOCAL DYSCOGNITIVE SEIZURES 45
811 HAEMATURIA 45
812 HYPERKALAEMIA 45
813 IMMUNE THROMBOCYTOPENIA 45
814 MYOKYMIA 45
815 PYELONEPHRITIS 45
816 RESPIRATORY ALKALOSIS 45
817 RETINAL DETACHMENT 45
818 SINUS BRADYCARDIA 45
819 SPINAL OPERATION 45
820 TROPONIN INCREASED 45
821 URINE ABNORMALITY 45
822 BLADDER DISORDER 44
823 CHRONIC SINUSITIS 44
824 HYPERVENTILATION 44
825 HYPOPHOSPHATAEMIA 44
826 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 44
827 IRIDOCYCLITIS 44
828 MULTIPLE ALLERGIES 44
829 NEUTROPHIL COUNT DECREASED 44
830 RED BLOOD CELL COUNT DECREASED 44
831 SEIZURE CLUSTER 44
832 SPINAL PAIN 44
833 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 44
834 TENDERNESS 44
835 BLOOD PRESSURE ABNORMAL 43
836 CONJUNCTIVITIS 43
837 CYANOSIS 43
838 HAEMATEMESIS 43
839 HAIR DISORDER 43
840 HALLUCINATIONS, MIXED 43
841 HOSTILITY 43
842 INFUSION SITE ERYTHEMA 43
843 MULTI-ORGAN FAILURE 43
844 PERICARDIAL EFFUSION 43
845 PHARYNGEAL SWELLING 43
846 PRODUCT USED FOR UNKNOWN INDICATION 43
847 ANKYLOSING SPONDYLITIS 42
848 APHTHOUS ULCER 42
849 DISSOCIATION 42
850 DYSGRAPHIA 42
851 DYSPHEMIA 42
852 ELECTROLYTE IMBALANCE 42
853 FEMUR FRACTURE 42
854 GENE MUTATION 42
855 HYPERTRANSAMINASAEMIA 42
856 LOCALISED INFECTION 42
857 MICTURITION URGENCY 42
858 MULTIPLE FRACTURES 42
859 PELVIC PAIN 42
860 RASH VESICULAR 42
861 SKIN IRRITATION 42
862 SPONDYLITIS 42
863 TOXIC EPIDERMAL NECROLYSIS 42
864 BLOOD PRESSURE DIASTOLIC INCREASED 41
865 BUNDLE BRANCH BLOCK RIGHT 41
866 DRUG WITHDRAWAL CONVULSIONS 41
867 EPILEPTIC ENCEPHALOPATHY 41
868 EXPIRED PRODUCT ADMINISTERED 41
869 FACIAL PARALYSIS 41
870 GALLBLADDER DISORDER 41
871 HUNGER 41
872 MUSCLE TIGHTNESS 41
873 OBSESSIVE-COMPULSIVE DISORDER 41
874 PERSONALITY CHANGE 41
875 PULMONARY HYPERTENSION 41
876 SELF-INJURIOUS IDEATION 41
877 SNORING 41
878 SPEECH DISORDER DEVELOPMENTAL 41
879 SUBSTANCE USE 41
880 ACCIDENTAL DEATH 40
881 CYST 40
882 FRACTURE 40
883 HAIR COLOUR CHANGES 40
884 HERNIA 40
885 HIATUS HERNIA 40
886 HYPERTONIA 40
887 MATERNAL EXPOSURE TIMING UNSPECIFIED 40
888 PRODUCT ADHESION ISSUE 40
889 PULMONARY MASS 40
890 SCREAMING 40
891 SKIN ODOUR ABNORMAL 40
892 ASCITES 39
893 BLOOD BICARBONATE DECREASED 39
894 BONE DENSITY DECREASED 39
895 BREAST PAIN 39
896 CLOSTRIDIUM DIFFICILE INFECTION 39
897 COLD SWEAT 39
898 DECREASED INTEREST 39
899 FORMICATION 39
900 HAEMOPTYSIS 39
901 INFUSION SITE SWELLING 39
902 MIGRAINE WITHOUT AURA 39
903 NERVE COMPRESSION 39
904 NODULE 39
905 ORAL HERPES 39
906 PRODUCT TASTE ABNORMAL 39
907 PSYCHOGENIC SEIZURE 39
908 STERNAL FRACTURE 39
909 TOOTH LOSS 39
910 TRIGEMINAL NEURALGIA 39
911 C-REACTIVE PROTEIN 38
912 DEVICE EXPULSION 38
913 INTENTIONAL DRUG MISUSE 38
914 INTERSTITIAL LUNG DISEASE 38
915 MENIERE^S DISEASE 38
916 MENSTRUATION IRREGULAR 38
917 OCULAR DISCOMFORT 38
918 PARKINSONISM 38
919 POISONING DELIBERATE 38
920 POST PROCEDURAL COMPLICATION 38
921 RHINITIS ALLERGIC 38
922 SLOW SPEECH 38
923 STILLBIRTH 38
924 SUBSTANCE ABUSE 38
925 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 38
926 SUSPECTED OFF LABEL USE 38
927 TENSION HEADACHE 38
928 ABDOMINAL PAIN LOWER 37
929 ACUTE MYOCARDIAL INFARCTION 37
930 ANTINUCLEAR ANTIBODY POSITIVE 37
931 BREAST DISORDER 37
932 GALACTORRHOEA 37
933 HEPATIC ENCEPHALOPATHY 37
934 HYSTERECTOMY 37
935 PATENT DUCTUS ARTERIOSUS 37
936 POOR VENOUS ACCESS 37
937 POST-TRAUMATIC NECK SYNDROME 37
938 RAYNAUD^S PHENOMENON 37
939 RESPIRATORY RATE INCREASED 37
940 RHINITIS 37
941 SJOGREN^S SYNDROME 37
942 STARING 37
943 SUPRAVENTRICULAR TACHYCARDIA 37
944 THERAPY CHANGE 37
945 ULCER 37
946 ACCIDENT 36
947 BRONCHIAL HYPERREACTIVITY 36
948 EYE INJURY 36
949 ORAL CANDIDIASIS 36
950 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 36
951 POLYARTHRITIS 36
952 TRANSAMINASES INCREASED 36
953 BLINDNESS TRANSIENT 35
954 BRONCHOSPASM 35
955 CALCULUS URINARY 35
956 DRUG DISPENSING ERROR 35
957 EOSINOPHILIA 35
958 FRUSTRATION TOLERANCE DECREASED 35
959 GENERAL SYMPTOM 35
960 HYPERLIPIDAEMIA 35
961 LEARNING DISORDER 35
962 LEFT VENTRICULAR DYSFUNCTION 35
963 MITOCHONDRIAL DNA MUTATION 35
964 PERSECUTORY DELUSION 35
965 POST PROCEDURAL INFECTION 35
966 SOFT TISSUE INJURY 35
967 TENDONITIS 35
968 VENTRICULAR TACHYCARDIA 35
969 WRIST FRACTURE 35
970 BLOOD SODIUM DECREASED 34
971 CEREBRAL ATROPHY 34
972 DRUG LEVEL BELOW THERAPEUTIC 34
973 ELECTROCARDIOGRAM ABNORMAL 34
974 FACE OEDEMA 34
975 FOETAL MALFORMATION 34
976 HEREDITARY ANGIOEDEMA 34
977 IDIOPATHIC INTRACRANIAL HYPERTENSION 34
978 IRON DEFICIENCY 34
979 LYMPHOPENIA 34
980 POLYURIA 34
981 PRODUCT USE COMPLAINT 34
982 SKIN FISSURES 34
983 ATTENTION DEFICIT HYPERACTIVITY DISORDER 33
984 BRAIN NEOPLASM 33
985 CARDIOVASCULAR DISORDER 33
986 CEREBRAL DISORDER 33
987 COLITIS ISCHAEMIC 33
988 ENCEPHALITIS 33
989 EYE DISCHARGE 33
990 GAMBLING DISORDER 33
991 GLOMERULAR FILTRATION RATE DECREASED 33
992 HYPERREFLEXIA 33
993 ISCHAEMIC CEREBRAL INFARCTION 33
994 LOSS OF LIBIDO 33
995 MALNUTRITION 33
996 NEPHROCALCINOSIS 33
997 NEW ONSET REFRACTORY STATUS EPILEPTICUS 33
998 PHOTOPSIA 33
999 RENAL TUBULAR NECROSIS 33